# Final Addendum Validation Summary (Updated Post-Scope Fix)

**Date**: 2026-05-26 (updated after reserved scope fix)

## Current Acceptance Classification
**CONDITIONALLY_ACCEPTED_WITH_EXTERNAL_BLOCKER**  
*(Tenant / Admin Consent Required)*

### Justification
- All local code, path, DB, static validation (ruff/mypy), and dry-run gates are green.
- The previous local defect (reserved scopes `offline_access` etc. being sent to MSAL) has been fixed by the central `sanitize_delegated_scopes()` implementation.
- The delegated auth flow now successfully reaches Microsoft Graph consent/permission enforcement.
- Full delegated Graph proof (and therefore production mail/calendar/file capabilities) is deferred pending **admin approval** of the required delegated Microsoft Graph permissions in the tenant.

This is an **external tenant/admin-consent blocker**, not a local implementation defect.

## Key Evidence from Latest Verification
- `auth status --json`: Shows correct `effective_msal_scopes` (reserved scopes stripped) and `removed_reserved_scopes`.
- `diagnostics graph --safe --json`: Reaches "Delegated token required" (past the previous reserved-scope error).
- `diagnostics proof delegated-graph --json`: Clean `blocked_no_token` with correct remediation ("Run auth login").
- Paths and DB: Fully ready (writable, no errors).

## TODO Next Commands After Admin Approval

Once the required delegated permissions (Mail.Read, Calendars.Read, Files.Read.All, etc.) have been approved by the tenant administrator:

```bash
source .venv/bin/activate

hb-assistant auth login --json
hb-assistant auth status --json
hb-assistant diagnostics graph --safe --json
hb-assistant diagnostics proof delegated-graph --json
hb-assistant diagnostics scan-sensitive --repo . --json
```

Commit the results when complete.

## Previous State
Prior to the scope sanitizer fix, the blocker was misclassified as DNS or a code defect (`NOT_ACCEPTED_FOR_DELEGATED_GRAPH_PROOF — RESERVED_SCOPE_AUTH_DEFECT`).

The scope sanitizer resolved the local defect. The evidence now accurately reflects the external nature of the remaining blocker.
